Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2026
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: January 16, 2026
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: January 11, 2026
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2025
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2025
Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors.
Journal: JCO oncology practice
Published: July 14, 2025
Examining Patient Characteristics in Bladder Cancer Clinical Trials Involving Immunotherapy.
Journal: Journal of clinical medicine
Published: December 17, 2024
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.
Journal: Journal for immunotherapy of cancer
Published: July 04, 2024
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: April 29, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancer.
Journal: Cancer
Published: April 25, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
Journal: Journal for immunotherapy of cancer
Published: January 22, 2024
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 08, 2023
Last Updated: 09/26/2026